Ontology highlight
ABSTRACT: Background
PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum.Objectives
The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines.Methods
This was a multicenter, open-label, repeat-dose, 1-year phase II safety study. Adults with moderate to severe glabellar lines at maximum frown, as independently assessed by both investigator and patient on the validated 4-point photonumeric Glabellar Line Scale (0 = no lines, 1 = mild, 2 = moderate, 3 = severe), were enrolled. On day 0, patients received an initial treatment (IT) of 20 U prabotulinumtoxinA (4 U/0.1 mL final vacuum-dried formulation injected into 5 glabellar sites). On and after day 90, patients received a repeat treatment (RT) if thei
SUBMITTER: Lorenc ZP
PROVIDER: S-EPMC8598184 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature